5 Pharmas Spending the Most to Develop Drugs
Branding: Financial Services Firm
Sotheby's Shareholder Presentation April 2014
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
October 8, 2011 Quarterly Meeting
Suffesa Monthly Review
